Pittenger & Anderson Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Pittenger & Anderson Inc’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-14,825	Closed	-$745K	–	383
2016 Q2	$745K	Buy	14,825 +5,125	+53%	+$273K	0.08%	184
2016 Q1	$519K	Sell	9,700 -325	-3%	-$19.1K	0.06%	200
2015 Q4	$658K	Buy	10,025 +8,275	+473%	+$511K	0.08%	175
2015 Q3	$99K	Hold	1,750	–	–	0.01%	277
2015 Q2	$103K	Buy	1,750 +500	+40%	+$30.8K	0.01%	281
2015 Q1	$78K	Hold	1,250	–	–	0.01%	292
2014 Q4	$72K	Buy	1,250 +625	+100%	+$34.8K	0.01%	287
2014 Q3	$34K	Buy	+625	New	+$33.1K	0.01%	297

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pittenger & Anderson Inc's TEVA Position: Q3 2016 in Review

Pittenger & Anderson Inc sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 14,825 shares — an estimated $745K sold.

Pittenger & Anderson Inc first reported a position in TEVA in Q3 2014 and held it in 8 quarters. The position peaked at $745K in Q2 2016. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Pittenger & Anderson Inc reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Pittenger & Anderson Inc sold 14,825 Teva Pharmaceuticals shares in Q3 2016, an estimated $745K.
Pittenger & Anderson Inc first reported a position in Teva Pharmaceuticals in Q3 2014 and held it in 8 quarters.
Pittenger & Anderson Inc's Teva Pharmaceuticals position peaked at $745K in Q2 2016.
795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Pittenger & Anderson Inc's 13F filing for Q3 2016, filed 14 Nov 2016.